Effect of N-Phenylanthranilic Acid Scaffold Nonsteroidal Anti-inflammatory Drugs on the Mitochondrial Permeability Transition. 2016

Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science.

Hepatotoxicity is a known side effect of nonsteroidal anti-inflammatory drugs (NSAIDs). In the present study, the effects of N-phenylanthranilic acid (NPA) scaffold NSAIDs on rat liver mitochondria were examined. Mefenamic acid (MEF, 200 µM) induced mitochondrial swelling, which was inorganic phosphate (Pi)-dependent and suppressed by cyclosporin A (CsA, 2.5 µM), similar to calcium-induced swelling. Mitochondrial swelling was also observed following the addition of 200 µM flufenamic acid (FLU), meclofenamic acid (MCL), and tolfenamic acid (TOL). Less swelling was observed with the addition of 200 µM diclofenac (DIC) or NPA. Diphenylamine (DPA)-induced swelling occurred in a Pi-independent manner and was not sensitive to CsA. The mechanism by which DPA interacted with the mitochondrial inner membrane differed from those of the other NPA scaffold NSAIDs. The addition of 50 µM MEF, MCL, TOL, and FLU had uncoupling effects in mitochondrial inner membrane. These NSAIDs dose-dependently obstructed electron transport in the respiratory chain. NSAIDs are known to have various dynamic structures, and the solvation free energies (dGWs: an index of stereo-hydrophobicity) of the conformers obtained were determined using a molecular orbital analysis. The relationship between the dynamic structures and swelling induced by NPA scaffold NSAIDs was also examined.

UI MeSH Term Description Entries
D008297 Male Males
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D004579 Electron Transport The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270) Respiratory Chain,Chain, Respiratory,Chains, Respiratory,Respiratory Chains,Transport, Electron
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
May 1984, Chemical & pharmaceutical bulletin,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
September 1983, Clinical rheumatology,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
March 2013, Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
April 1982, Planta medica,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
August 1984, Chemical & pharmaceutical bulletin,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
August 2011, Equine veterinary journal. Supplement,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
October 2007, Nihon rinsho. Japanese journal of clinical medicine,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
April 1992, Clinics in podiatric medicine and surgery,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
May 1990, Clinics in geriatric medicine,
Yohei Tatematsu, and Hiroki Hayashi, and Ryo Taguchi, and Haruhi Fujita, and Atsushi Yamamoto, and Kazuto Ohkura
January 1982, Pharmacology,
Copied contents to your clipboard!